Prognosis value of positron emission tomography using F18-fluorodeoxyglucose (FDG-PET) in the setting of ASCT in patients with high grade non-Hodgkin lymphoma (HGNHL).

被引：0
|
作者：
Bodet-Milin, C.
Rolland, V.
Oudoux, A.
Aansquer, C.
Le Goille, S.
Valette, F.
Rousseau, C.
Dupas, B.
Moreau, P.
Harrousseau, J.
Kraeber-Bodere, F.
机构：
[1] Univ Hosp, Nantes, France
[2] Ctr Canc, Nantes, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [1] Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low grade non-Hodgkin's lymphoma (NHL).
    Jerusalem, G
    Beguin, Y
    Najjar, F
    Hustinx, R
    Fassotte, MF
    Rigo, P
    Fillet, G
    BLOOD, 2000, 96 (11) : 328A - 328A
  • [2] Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)
    Jerusalem, G
    Beguin, Y
    Najjar, F
    Hustinx, R
    Fassotte, MF
    Rigo, P
    Fillet, G
    ANNALS OF ONCOLOGY, 2001, 12 (06) : 825 - 830
  • [3] F-18FDG positron emission tomography in non-Hodgkin lymphoma of the breast
    Kumar, R
    Xiu, Y
    Dhurairaj, T
    Yu, XQ
    Alavi, A
    Zhuang, HM
    CLINICAL NUCLEAR MEDICINE, 2005, 30 (04) : 246 - 248
  • [4] The utility and prognostic value of positron emission tomography with fluorine-18-fluoro-2-d-glucose (FDG-PET) on patients with Hodgkin and non-Hodgkin lymphoma
    Ozturk, B.
    Benekli, M.
    Akdemir, U. O.
    Buyukberber, S.
    Coskun, U.
    Uner, A.
    Unlu, M.
    Yamac, D.
    Kitapci, M.
    Yaman, E.
    Yildiz, Ramazan
    Demirel, Umut
    Kaya, Ali O.
    Kapucu, Ozlem
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Value of [18F]fluorodeoxyglucose-positron emission tomography in managing patients with aggressive non-Hodgkin's lymphoma
    Meignan, Michel
    Haioun, Corinne
    Itti, Emmanuel
    Rahmouni, Alain
    Reyes, Felix
    CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (04): : 306 - 313
  • [6] 18F)fluorodeoxyglucose positron emission tomography (FDG-PET) for the evaluation of patients (pts) with follicular lymphoma (FL)
    Vigliotti, M
    Cascini, G
    Della Cioppa, P
    Corazzelli, G
    De Chiara, A
    Russo, F
    Frigeri, F
    D'Arena, G
    Marcacci, G
    Aloj, L
    Lastoria, S
    Pinto, A
    ANNALS OF ONCOLOGY, 2005, 16 : 121 - 121
  • [7] Detection of regional and distant metastases in esophageal cancer using F18-fluorodeoxyglucose (FDG) positron emission tomography (PET)
    Brown, AL
    Skehan, SJ
    Pelling, M
    Rawlinson, J
    Young, JE
    Nahmias, C
    RADIOLOGY, 1998, 209P : 169 - 169
  • [8] Midtreatment 18F-Fluorodeoxyglucose Positron-Emission Tomography in Aggressive Non-Hodgkin Lymphoma
    Zinzani, Pier Luigi
    Gandolfi, Letizia
    Broccoli, Alessandro
    Argnani, Lisa
    Fanti, Stefano
    Pellegrini, Cinzia
    Stefoni, Vittorio
    Derenzini, Enrico
    Quirini, Federica
    Baccarani, Michele
    CANCER, 2011, 117 (05) : 1010 - 1018
  • [9] Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients:: when do we really need FDG-PET?
    Reinhardt, MJ
    Herke, C
    Altehoefer, C
    Finke, J
    Moser, E
    ANNALS OF ONCOLOGY, 2005, 16 (09) : 1524 - 1529
  • [10] Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma:: Is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
    Spaepen, K
    Stroobants, S
    Dupont, P
    Van Steenweghen, S
    Thomas, J
    Vandenberghe, P
    Vanuytsel, L
    Bormans, G
    Balzarini, J
    De Wolf-Peeters, C
    Mortelmans, L
    Verhoef, G
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 414 - 419
12345